The speed of scientific and technological changes and accomplishments of the medical research field, place an increasing demand on clinicians to adapt to new techniques and therapies. Immunotherapy is one of those rapidly developing treatments, with promising components like chimeric-antigen-receptor therapy (CAR T).
Following these developments, EHA launched the Topics-in-Focus Program, one dedicated to immunotherapy
CAR T Cell Net
In immunotherapy, it is CAR T cell therapy that takes center stage. CAR T Cell Net provides an overview of all activities EHA is developing in this field in a way that is easy to navigate and accessible to anyone. We also provide the latest news on CAR T and hope to inspire and serve everyone interested in the field.